EPJ Plus – Focus on Hadron Therapy in Europe
- Details
- Published on 10 August 2011
Oncological hadron therapy was first proposed 65 years ago by Robert R. Wilson, and it took more than 40 years to build the first dedicated facility, in Loma Linda in the nineties. The growth of new facilities since then has been exponential, and thousands of patients are now treated every year. Close collaboration between research institutes, clinical centers and industry is the basis and the future of this field. This EPJ Plus focus issue spotlights the status of hadron therapy in Europe, where different centers are already in operation, some are just now ready to start patient treatments, and new ones are being planned. more
Topical Collections
Open calls for papers
-
EPJ AM Call for papers: Themed Issue on Global Advances in Electromagnetic Metasurfaces for Space
(EPJ AM)
-
Call for papers : Special Issue on Imaging, Diffraction, and Spectroscopy on the micro/nanoscale
(EPJ AP)
-
EPJ B Topical Issue: High Field Superconducting Magnets: Materials, Technology and Applications
(EPJ B)
-
EPJ N Topical Issue on Research Reactor use and projects on modeling and experimental breakthroughs for Advanced Nuclear Reactors
(EPJ N)
-
EPJ Plus Focus Point Issue: Layered Transition Metal Dichalcogenides (TMDs): Properties, Engineering, and Applications
(EPJ PLUS)